FRI 708-718 Novel Treatment for Diabetes- Focusing on GLP-1 and SGLT2 (posters)

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Diabetes & Glucose Metabolism-Clinical
Friday, April 1, 2016: 1:15 PM-3:15 PM
Exhibit/Poster Hall (BCEC)

Nitesh D Kuhadiya, MD, MPH1, Aditya Mehta2, Husam Ghanim, PhD3, Manisha Garg, MD4, Jeanne Hejna5, Antoine Makdissi, MD6, Ajay Chaudhuri, MBBS, MRCP2, Manav Batra, MD7 and Paresh Dandona, MD, PHD, FRCP, FACP, FACE2, (1)Endocrinology, Diabetes and Endocrinology Center of Western New York, Buffalo, NY
(2)Diabetes and Endocrinology Center of Western New York, Buffalo, NY
(3)Medicine, State University of New York at Buffalo, Buffalo, NY
(4)Department of Endocrinology, Diabetes and Endocrinology Center of Western New York, Buffalo, NY
(5)Suny at Buffalo
(6)Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Buffalo, NY
(7)Endocrinology, University at Buffalo, Buffalo, NY
Poster Board Number: FRI 708
Su Kyoung Kwon1, Bu Kyung Kim2, Young-Sik Choi2, So Young Ock2, Min Jung Jung3, Jeonghoon Heo4, Jeong Hoon Kim5 and Sookja Kim4, (1)Endocrinology and Metabolism, Internal Medicine, Kosin University College of Medicine, Busan, South Korea
(2)Dept of Endocrinology & Metabolism, Kosin Univ Sch of Med, Busan, South Korea
(3)Pathology, Kosin university College of Medicine, Busan, South Korea
(4)Molecular Biology and Immunology, Kosin University College of Medicine
(5)Surgery, Kosin University College of Medicine, Los Angeles, CA
Poster Board Number: FRI 709
Helene Hausner1, Thomas William Anderson1, Julie Derving Karsbøl1, Anders Gaarsdal Holst1, Jacob Bonde Jacobsen1, Frank Wagner2 and Georg Golor3, (1)Novo Nordisk A/S, Søborg, Denmark
(2)Charité Research Organisation GmbH, Berlin, Germany
(3)Parexel International GmbH, Berlin, Germany
Poster Board Number: FRI 710
Juan Pablo Frías, National Research Institute, Los Angeles, CA, James A Ruggles, PhD, Medical Affairs, Diabetes, AstraZeneca, Fort Washington, PA, Sergey Zhuplatov, MD, PhD, Medical Affairs Diabetes, AstraZeneca, Southampton, PA, Samer Nakhle, MD, Palm Medical Research, Las Vegas, NV, Eric Klein, MD, Capital Clinical Research Center, Olympia, WA, John Pullman, MD, FACP, Clinical Trials, Mercury St. Medical Group, Butte, MT, Rong Zhou, PhD, Biostatistics, Medpace, Cincinnati, OH and Poul Strange, MD, PhD, Integrated Medical Development, Princeton Junction, NJ
Poster Board Number: FRI 711
Graydon S Meneilly, MD, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, Hasan Alawi, Dr med, Private Practice, Diabetessaar-Center, Saarlouis, Germany, George E Dailey III, MD, Endocrinology, Diabetes & Metabolism, Scripps Whittier Diabetes Institute, San Diego, CA, Carlos Trescoli, MD, Geriatric Medicine, Hospital de la Ribera, Alzira, Spain, Helard Manrique Hurtado, MD, Endocrinology, Centro De Investigacion En Diabetes, Obesidad Y Nutrición, Lima, Peru, Hailing Guo, Biostatistics, BMD Consulting Inc., Somerset, NJ, Christine Roy-Duval, MD, Research and Development, Sanofi, Chilly-Mazarin, France, Valerie Pilorget, MD, Medical Operations, Clinical Sciences and Operations, Sanofi Research and Development, Sanofi, Chilly-Mazarin, France, Riccardo Perfetti, MD, Global Medical Affairs, Diabetes Division, Sanofi, Bridgewater, NJ and Hamish Simpson, MD, GP Practice, Townhead Surgery, Irvine, United Kingdom
Poster Board Number: FRI 712
Yumi Harano, Midori Yasui and Akira Babazono, Department of Healthcare Administration and Management, Graduate School of Medical Sciences, Kyushu University
Poster Board Number: FRI 714
Simant Thapa, MD, Internal Medicine, St.Vincent Hospital, Worcester, MA, Nitin Trivedi, MD, Medicine, Division of Endocrine and Metabolic Medicine, St.Vincent Hospital, Worcester, MA and Abdulkadir Omer, MD, Medicine, Division of Endocrine, Diabetes and Metabolic Medicine, St.Vincent Hospital, Worcester, MA
Poster Board Number: FRI 715
Soo Lim1, Kyungwan MIN2, JaeMyung Yu3, Parinya Chamnan4, Eun Sook Kim5, Kun-Ho Yoon6, Sam Kwon7, Min Kyong Moon8, Kwan Woo Lee9, Dong-Jun Kim10, Mikyung Kim11, Manaj Wongtanate12, Eun Young Kim13, Sung-Ho Kim13 and Moon-Kyu Lee14, (1)Seoul National University Bundang Hospital, Seongnam, South Korea
(2)Eulji University Medical Center, Seoul, South Korea
(3)Kangnam Sacred Heart Hospital, Seoul, South Korea
(4)Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand
(5)Ulsan University Hospital, Ulsan, South Korea
(6)Seoul St. Mary’s Hospital, Seoul, South Korea
(7)Samsung Changwon Hospital, Changwon, South Korea
(8)Seoul Metropolitan Government Seoul National University Boramae Medical, Seoul, South Korea
(9)Ajou University Hospital, Suwon, South Korea
(10)Inje University Ilsan Paik Hospital, Goyang, South Korea
(11)Inje University Haeundae Paik Hospital, Busan, South Korea
(12)Nan Hospital, Nan, Thailand
(13)LG Life Sciences, Seoul, South Korea
(14)Samsung Medical Center, Seoul, South Korea
Poster Board Number: FRI 716
Jochen R Seufert, Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, Germany, Sanjay Patel, MB ChB, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, Egon Pfarr, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany, Angelo Del Parigi, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT and Christopher Lee, Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany
Poster Board Number: FRI 717
Stephan Matthaei, MD1, Aleksander Celinski, MD, PhD2, Doina Catrinoiu, MD, PhD3, Lars Hansen, MD, PhD4, Hungta Chen, PhD5, Ricardo Garcia-Sanchez, MD5, Alex Chin, PharmD5 and Nayyar Iqbal, MD5, (1)Diabetes Center, Quakenbrück, Germany
(2)CenterMed - Centrum Badañ Klinicznych, Kraków, Poland
(3)Spitalul Clinic Judetean de Urgenta Constanta, Constanta, Romania
(4)Bristol-Myers Squibb, Princeton, NJ
(5)AstraZeneca, Gaithersburg, MD
Poster Board Number: FRI 718

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire